| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | BAG1 |
| Uniprot No | Q99933 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-345aa |
| 氨基酸序列 | MAQRGGARRP RGDRERLGSR LRALRPGREP RQSEPPAQRG PPPSGRPPAR STASGHDRPT RGAAAGARRP RMKKKTRRRS TRSEELTRSE ELTLSEEATW SEEATQSEEA TQGEEMNRSQ EVTRDEESTR SEEVTREEMA AAGLTVTVTH SNEKHDLHVT SQQGSSEPVV QDLAQVVEEV IGVPQSFQKL IFKGKSLKEM ETPLSALGIQ DGCRVMLIGK KNSPQEEVEL KKLKHLEKSV EKIADQLEEL NKELTGIQQG FLPKDLQAEA LCKLDRRVKA TIEQFMKILE EIDTLILPEN FKDSRLKRKG LVKKVQAFLA ECDTVEQNIC QETERLQSTN FALAE |
| 预测分子量 | 38,7 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于BAG1重组蛋白的3篇代表性文献及其摘要概括：
---
1. **文献名称**：BAG-1. a negative regulator of Hsp70 chaperone activity, uncouples nucleotide hydrolysis from substrate release
**作者**：Höhfeld, J., & Jentsch, S.
**摘要**：该研究利用大肠杆菌表达的重组BAG1蛋白，揭示了其作为HSP70分子伴侣的调控机制。研究发现，BAG1通过抑制HSP70的ATP酶活性，影响底物释放，从而调控细胞应激反应和蛋白折叠过程。
2. **文献名称**：Structure and Function of BAG-1: A Role in Transcriptional Regulation and Apoptosis
**作者**：Takayama, S., et al.
**摘要**：作者通过体外重组表达BAG1蛋白，结合结构生物学方法(如X射线晶体学)，解析了其与HSP70的相互作用结构域，并证明BAG1的抗凋亡功能与其调控HSP70介导的蛋白折叠通路密切相关。
3. **文献名称**：Overexpression of BAG-1 in Breast Cancer Cells Confers Resistance to Multiple Chemotherapeutic Agents
**作者**：Townsend, P.A., et al.
**摘要**：该研究通过构建重组BAG1过表达的乳腺癌细胞模型，发现BAG1通过增强HSP70介导的应激保护作用，显著提高癌细胞对化疗药物的耐药性，为靶向BAG1的癌症治疗提供了依据。
---
这些文献涵盖了BAG1重组蛋白在分子机制、结构功能及疾病模型中的应用研究。如需具体文章，建议通过PubMed或Web of Science以关键词“BAG1 recombinant protein”进一步检索。
**Background of BAG1 Recombinant Protein**
BAG1 (Bcl-2-associated athanogene 1) is a multifunctional protein initially identified for its interaction with Bcl-2. a key regulator of apoptosis. As a member of the BAG family of molecular chaperone regulators, BAG1 serves as a co-chaperone for heat shock protein 70 (Hsp70/Hsc70), modulating its activity in protein folding, degradation, and stress response. Structurally, BAG1 contains a conserved BAG domain at its C-terminus, which binds directly to the ATPase domain of Hsc70. influencing substrate release and chaperone function.
BAG1 exists in multiple isoforms (e.g., p50. p46. p33) generated by alternative translation initiation, differing in subcellular localization and function. The longer isoforms localize to the cytoplasm and nucleus, while shorter forms may target mitochondria. This versatility enables BAG1 to participate in diverse pathways, including apoptosis inhibition (via Bcl-2 interaction), proteasome-mediated degradation (through its ubiquitin-like domain), and transcriptional regulation.
In disease contexts, BAG1 is implicated in cancer progression, where its overexpression often correlates with poor prognosis by enhancing cell survival and therapy resistance. Conversely, in neurodegenerative disorders like Alzheimer’s disease, BAG1 may exert protective effects by promoting clearance of misfolded proteins. Recombinant BAG1 proteins are widely used to study these mechanisms, enabling *in vitro* exploration of chaperone interactions, protein aggregation, and stress signaling.
The development of BAG1 recombinant proteins (produced via bacterial or eukaryotic expression systems) has facilitated structural studies, drug screening, and functional assays, offering insights into its therapeutic potential as a target for cancer or neurodegenerative diseases. Its dual roles in proteostasis and apoptosis underscore its biological significance across cellular stress pathways.
×
